G456 (Amphetamine and Dextroamphetamine Extended Release 30 mg)
Pill with imprint G456 is Beige / Brown, Capsule-shape and has been identified as Amphetamine and Dextroamphetamine Extended Release 30 mg. It is supplied by Impax Generics.
Amphetamine/dextroamphetamine is used in the treatment of adhd; narcolepsy; fatigue and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Amphetamine/dextroamphetamine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for G456
Amphetamine and Dextroamphetamine Extended Release
- Imprint:
- G456
- Strength:
- 30 mg
- Color:
- Beige / Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Impax Generics
- National Drug Code (NDC):
- 00115-1491
More about amphetamine/dextroamphetamine
- Amphetamine/dextroamphetamine Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 673 Reviews
- Drug class: CNS stimulants
Consumer resources
- Amphetamine and dextroamphetamine
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)
- Dextroamphetamine and Amphetamine Extended-Release Capsules (Mydayis)
- Dextroamphetamine and Amphetamine Tablets
- Dextroamphetamine and amphetamine (Advanced Reading)
Other brands: Adderall, Adderall XR, Mydayis
Professional resources
- Amphetamine Sulfate (AHFS Monograph)
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate ER Capsules (FDA)
- Dextroamphetamine and Amphetamine (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
